Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-07-25
2006-07-25
Balasubramanian, Venkataraman (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S251000
Reexamination Certificate
active
07081462
ABSTRACT:
The present invention discloses compounds corresponding to formula I:wherein A, Z, Z1, Y, R1and R2are as defined in the specification, as well as pharmaceutical formulations, methods of making and uses thereof.
REFERENCES:
patent: 4522947 (1985-06-01), Musser et al.
patent: 4650737 (1987-03-01), Wiedemann
patent: 4656281 (1987-04-01), Musser et al.
patent: 4831040 (1989-05-01), Decktor et al.
patent: 0542497 (1993-05-01), None
patent: 11-292878 (1998-04-01), None
patent: WO 02/064594 (2002-08-01), None
Wolft Manfred E. “Burger's Medicinal Chemistry, 5ed, Part 1”, John Wiley & Sons, 1995, pp. 975-977.
Banker, G.S. et al, “Modern Pharmaceutices, 3ed.”, Marcel Dekker, New York. 1996, pp. 451 and 596.
Cecil Textbook of Medicine, edited by Bennet, J.C., and Plum F., 20th edition, vol. 1, 1004-1010, 1996.
See Graninger et al. Curr. Opin. Rheumatol. 13(3): 209-213.
Nagarkatti et al. J. Mol. Cell Cardiol. 30(8): 1651-1664, 1998.
Brunet et al., Esaays Biochem. 32 : 1-16, 1997.
Herlaar et al. Mol. Med. Today 5(10) 439-447, 1999.
Goldstein David Michael
Hawley Ronald Charles
Lui Alfred Sui-Ting
Sjogren Eric Brian
Balasubramanian Venkataraman
Green Grant D.
Roche Palo Alto LLC
LandOfFree
Imidazo-substituted compounds as p38 kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazo-substituted compounds as p38 kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazo-substituted compounds as p38 kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3524391